Valerie W Rusch Selected Research

Lymph Node Excision (Lymph Node Dissection)

9/2023	Process Improvement in Lymphadenectomy for Lung Cancer: The Wave of the Future?
1/2017	Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
5/2015	Chylothorax and Recurrent Laryngeal Nerve Injury Associated With Robotic Video-Assisted Mediastinal Lymph Node Dissection.
5/2011	Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
3/2011	Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
1/2010	Optimum lymphadenectomy for esophageal cancer.
2/2007	Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
11/2006	Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care?
3/2006	Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valerie W Rusch Research Topics

Disease

92	Neoplasms (Cancer) 05/2024 - 01/2002
37	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2002
32	Malignant Mesothelioma 12/2023 - 07/2003
29	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2002
20	Adenocarcinoma 11/2023 - 11/2004
16	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2002
14	Adenocarcinoma of Lung 10/2022 - 04/2006
12	Mesothelioma 02/2024 - 05/2002
8	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 08/2003
5	Carcinoma (Carcinomatosis) 11/2011 - 07/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 05/2004
4	Atrial Fibrillation 01/2022 - 03/2007
4	Pain (Aches) 01/2021 - 05/2006
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2014 - 02/2011
3	Disease Progression 01/2023 - 10/2016
3	Residual Neoplasm 12/2017 - 11/2005
3	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 05/2004
3	Pathologic Complete Response 01/2016 - 02/2007
3	Hemorrhage 09/2011 - 09/2003
3	Thymoma (Thymic Carcinoma) 07/2009 - 12/2007
3	Infections 11/2006 - 01/2006
2	Leukemia 01/2023 - 02/2016
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Anastomotic Leak 04/2020 - 01/2019
2	Microsatellite Instability 12/2019 - 01/2018
2	Esophageal Squamous Cell Carcinoma 01/2019 - 03/2009
2	Lymphatic Metastasis 01/2017 - 11/2006
2	Wounds and Injuries (Trauma) 11/2014 - 07/2009
2	Malignant Pleural Effusion 04/2011 - 01/2011
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2008 - 11/2004
1	Frailty 01/2023
1	Neurofibromatoses (Neurofibromatosis) 01/2023
1	Vaccinia 01/2023
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2023
1	Fever (Fevers) 03/2022
1	Myocardial Infarction 01/2022
1	Pneumonia (Pneumonitis) 01/2022

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 10/2019 - 04/2006
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2011
7	MesothelinIBA 11/2023 - 03/2012
7	Tyrosine Kinase InhibitorsIBA 10/2022 - 02/2008
7	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 07/2003
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2007
5	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 05/2007
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 04/2006
5	Pemetrexed (MTA)FDA Link 02/2016 - 07/2003
4	Gefitinib (Iressa)FDA Link 05/2011 - 04/2006
3	atezolizumabIBA 10/2023 - 10/2022
3	PlatinumIBA 11/2022 - 07/2011
3	Circulating Tumor DNAIBA 11/2022 - 12/2017
3	Bevacizumab (Avastin)FDA Link 12/2016 - 02/2011
3	Colloids (Colloid)IBA 03/2013 - 02/2011
3	Tumor Biomarkers (Tumor Markers)IBA 07/2011 - 11/2004
2	Monoclonal AntibodiesIBA 01/2023 - 01/2019
2	B7-H1 AntigenIBA 01/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 12/2011
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 12/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 11/2012
2	AntigensIBA 09/2017 - 05/2012
2	AsbestosIBA 02/2016 - 01/2016
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2014 - 05/2002
2	MucinsIBA 08/2014 - 02/2011
2	Etoposide (VP 16)FDA LinkGeneric 08/2014 - 08/2009
2	enhanced green fluorescent proteinIBA 01/2011 - 08/2003
2	Phosphotransferases (Kinase)IBA 07/2008 - 05/2007
2	Therapeutic UsesIBA 01/2007 - 08/2005
2	Green Fluorescent ProteinsIBA 11/2006 - 05/2006
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2006 - 01/2002
1	Peptides (Polypeptides)IBA 11/2023
1	AntibodiesIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	avelumabIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2022
1	Chimeric Antigen ReceptorsIBA 03/2022
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022

Therapy/Procedure

66	Therapeutics 01/2023 - 01/2002
23	Radiotherapy 02/2024 - 07/2002
20	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
15	Esophagectomy 01/2023 - 02/2007
13	Neoadjuvant Therapy 12/2023 - 02/2007
13	Pneumonectomy (Lung Volume Reduction) 01/2022 - 08/2003
13	Thoracotomy 01/2019 - 07/2003
9	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 03/2006
9	Induction Chemotherapy 01/2023 - 05/2006
8	Immunotherapy 04/2024 - 12/2011
5	Adjuvant Chemotherapy 10/2019 - 10/2011
4	Segmental Mastectomy (Lumpectomy) 05/2024 - 10/2014
4	Chemoradiotherapy 08/2013 - 02/2007
3	Length of Stay 09/2012 - 03/2007
2	Precision Medicine 10/2022 - 12/2017
2	Aftercare (After-Treatment) 09/2017 - 09/2014
2	Investigational Therapies (Experimental Therapy) 01/2015 - 02/2008
2	Decompression 11/2014 - 01/2011
2	Drug Tapering 01/2007 - 08/2005
1	Electronic Nose 05/2024